CLOS
GBIO

Compagnie Lombard Odier SCmA’s Generation Bio GBIO Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-105
Closed -$5.51K – 677
2022
Q3 		$6K Hold
105
– – ﹤0.01% 586
2022
Q2 		$7K Hold
105
– – ﹤0.01% 557
2022
Q1 		$8K Hold
105
– – ﹤0.01% 554
2021
Q4 		$7K Hold
105
– – ﹤0.01% 636
2021
Q3 		$27K Hold
105
– – ﹤0.01% 544
2021
Q2 		$28K Hold
105
– – ﹤0.01% 529
2021
Q1 		$30K Hold
105
– – ﹤0.01% 552
2020
Q4 		$30K Buy
+105
New +$33.7K ﹤0.01% 482

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Compagnie Lombard Odier SCmA's GBIO Position: Q4 2022 in Review

Compagnie Lombard Odier SCmA sold out of Generation Bio (GBIO) in Q4 2022, closing a stake of 105 shares — an estimated $5.51K sold.

Compagnie Lombard Odier SCmA first reported a position in GBIO in Q4 2020 and held it in 8 quarters. The position peaked at $30K in Q1 2021. 95 funds tracked by Wall St. Rank hold GBIO as of Q4 2022.

  • Compagnie Lombard Odier SCmA reported no remaining Generation Bio position as of Q4 2022 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 105 Generation Bio shares in Q4 2022, an estimated $5.51K.
  • Compagnie Lombard Odier SCmA first reported a position in Generation Bio in Q4 2020 and held it in 8 quarters.
  • Compagnie Lombard Odier SCmA's Generation Bio position peaked at $30K in Q1 2021.
  • 95 funds tracked by Wall St. Rank held Generation Bio as of Q4 2022.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2022, filed 13 Feb 2023.